Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

著者: Meredith M. Regan, Patrick Neven, Anita Giobbie‐Hurder, Aron Goldhirsch, Bent Ejlertsen, L. Mauriac, John Forbes, Ian Smith, István Láng, Andrew Wardley, Manuela Rabaglio, Karen N. Price, Richard D. Gelber, Alan S. Coates, Beat Thürlimann - The Lancet 2011 被引用: 408